Funding Cancellation for mRNA Vaccine Development
Health and Human Services (HHS) has decided to halt the $766 million allocated to Moderna for the development of additional mRNA vaccines. This decision has led to significant criticism from former officials of the Biden administration.
Former health officials argue that continuing the development of these vaccines is essential, especially in light of potential pandemic threats. Yet, they haven’t really explained why mRNA vaccines are necessary compared to traditional methods.
“The administration’s actions hinder our ability to respond to biological threats,” commented Beth Cameron, a senior adviser at the Brown University Pandemic Center and a former director at the White House National Security Council. “This cancellation signals a shift in our approach to pandemic preparedness, which isn’t good for the country,” she noted.
Despite the backlash, the HHS cited insufficient surveillance and long-term testing during the previous administration as reasons for its reversal.
Historically, mRNA technology was utilized for creating the Covid-19 vaccine.
“After a thorough review, we determined that continuing funding for Moderna’s H5N1 mRNA vaccines isn’t scientifically or ethically reasonable,” said Andrew Nixon, director of HHS Communications. “It’s not just about effectiveness; it’s about safety and public trust. mRNA technology remains inadequately tested, and this decision prevents further questionable spending,” he explained.
This cancellation illustrates a notable shift in vaccine policy from the previous Trump administration, contrasting the Biden administration’s handling of Covid-19.
In response, Moderna expressed concern over the uncertainty this funding end brings.
“Although the loss of HHS funding adds uncertainty, we are encouraged by the strong immune response and safety profile seen in early analysis of the H5 avian influenza vaccine trial,” a spokesperson shared.
“These clinical results emphasize the crucial role that mRNA technology has played in addressing emerging health challenges,” they added.
